CD3EAP Antibody (N-term) Blocking Peptide

Produktübersicht

• Artikelname: CD3EAP Antibody (N-term) Blocking Peptide
• Artikelnummer: ABT-BP8607A
• Hersteller Artikelnummer: BP8607a
• Alternativnummer: ABT-BP8607A-500UG
• Hersteller: Abcepta
• Kategorie: Proteine/Peptide
• Alternative Synonym: DNA-directed RNA polymerase I subunit RPA34, A345, Antisense to ERCC-1 protein, ASE-1, CD3-epsilon-associated protein, CAST, CD3E-associated protein, RNA polymerase I-associated factor PAF49, CD3EAP, ASE1, CAST, PAF49

Produktbeschreibung

CD3EAP is a DNA dependent RNA polymerase which catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. It is a component of RNA polymerase I which synthesizes ribosomal RNA precursors. Isoform 1 is involved in UBTF activated transcription, presumably at a step following PIC formation.

Produkteigenschaften

• NCBI: 10849
• UniProt: O15446
• Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
• Target-Kategorie: The synthetic peptide sequence used to generate the antibody AP8607a was selected from the N-term region of human CD3EAP. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.